Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Altimmune plunges as Kerrisdale Capital goes short the stock

Published 02/13/2024, 10:41 AM
Updated 02/13/2024, 10:44 AM
© Reuters.  Altimmune (ALT) plunges as Kerrisdale Capital goes short the stock

Altimmune (NASDAQ:ALT) shares dropped Tuesday after Kerrisdale Capital said it is short the company's shares.

Investors in the pharmaceutical company "are in for a rude awakening," claims Kerrisdale. They argue that "a deeper examination of Altimmune's data reveals its drug has "little chance of competing against either the approved incumbents or the other GLP-1 agonists progressing through clinical trials."

"We don't think legitimate prospective partners want to spend hundreds of millions of dollars and years of trials pursuing an obvious dead end," the firm claims.

The short-seller also took aim at the company's management in its note, claiming they will struggle to get an edge over Novo Nordisk or Eli Lilly.

ALT shares are currently down more than 14% at $9.90 per share. The stock initially fell as low as $8.38.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.